HeartSciences (HSCSW) Payables (2022 - 2026)

HeartSciences (HSCSW) has reported Payables for 5 consecutive years, with $3.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Payables rose 26.21% year-over-year to $3.6 million; the trailing twelve-month figure through Apr 2026 stood at $3.6 million (up 26.21% YoY), and the FY2026 full-year result was $3.6 million, up 26.21% from the prior year.
• Payables climbed to $3.6 million in Q2 2026 per HSCSW's latest filing, from $2.9 million in the prior quarter.
• Across five years, Payables topped out at $3.6 million in Q2 2026 and bottomed at $396506.0 in Q3 2024.
• Historically, Payables has averaged $1.8 million across 5 years, with a median of $1.8 million in 2025.
• The widest YoY moves for Payables: up 360.11% in 2025, down 69.08% in 2025.
• Over 5 years, Payables stood at $1.9 million in 2022, then soared by 30.13% to $2.5 million in 2023, then rose by 5.52% to $2.6 million in 2024, then increased by 8.56% to $2.9 million in 2025, then climbed by 26.21% to $3.6 million in 2026.
• According to Business Quant data, Payables over the past three periods registered $3.6 million, $2.9 million, and $817390.0 for Q2 2026, Q4 2025, and Q4 2025 respectively.